Moderna Releases Q3 Earnings as It Confirms Its Geared Up Activity to Meet Up with Its Vaccine Demand
Massachusetts-Based biotechnology company Moderna Inc (NASDAQ: MRNA), one of the top pharmaceutical companies in search of a COVID-19 vaccine, has released its Q3 financial earnings while confirming its preparations to meet up with the expected surge in demand for its vaccine once approved.